NASDAQ$NERV

Minerva Neurosciences Inc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

NERV Q3 2024 — $100.0M revenue

These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, per. Minerva Neurosciences Inc reported Q3 2024 results. Net income of $21.0M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.

  • Revenue: $100.0M.
  • Net income: $21.0M.
  • Filed on Form 10-Q (accession 0000950170-24-121063).

Headline financials

Total Revenue

$26.6M

Previous: $0.00
EPS

$2.97

Previous: -$1.03+388.3%
Capital Expenditures

$0.00

Previous: $0.00
Free Cash Flow

$22.5M

Previous: -$4.81M+568.4%
Net Income

$22.5M

Previous: -$7.82M+387.9%
Operating Income

-$4.37M

Previous: -$6.08M+28.2%
Gross Profit

$26.6M

Previous: -$7.75K+343276.8%
R&D Expense

$1.89M

Previous: $3.44M-45.2%
Stock-Based Comp

$308K

Previous: $372K-17.3%

Revenue & EPS history

Minerva Neurosciences · Revenue · Quarterly

$26.6M

Q3 2024

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-1.6%

Avg return

Earnings day

-3.7%

Avg return

5 days after

+24.7%

Avg return

30 days after

38%

16 / 42 earnings

Positive

+20.6%

Q1 2021

Best reaction

-27.7%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-1.3%-7.1%
Q3 2025-3.9%-2.9%-2.1%
Q2 2025-2.8%-7.0%+22.0%
Q1 2025-0.1%-8.0%+9.4%
Q4 2024+0.0%-6.7%+1.1%
Q3 2024-0.4%+1.0%-8.6%
Q2 2024+2.1%+2.9%-7.5%
Q1 2024-0.4%-0.8%+8.1%
Q4 2023-21.9%-68.2%-69.7%
Q3 2023-3.0%-24.1%+10.5%
Q2 2023+10.6%+2.0%-12.0%
Q1 2023-22.4%-7.7%+3.4%
Q4 2022-10.8%-15.1%-19.5%
Q3 2022+13.3%+2.2%+3.8%
Q2 2022-27.7%-30.4%+123.0%
Q1 2022+1.0%-16.2%-18.6%
Q4 2021+0.5%-5.1%+17.6%
Q3 2021+8.1%-3.0%-28.4%
Q2 2021-3.8%-0.5%-3.3%
Q1 2021+20.6%+48.7%+936.6%
Q4 2020+8.7%+16.8%-7.7%
Q3 2020-2.8%+7.5%-14.3%
Q2 2020+7.9%+3.0%-9.6%
Q1 2020+1.5%+22.4%-58.1%
Q4 2019-13.9%-25.1%-32.1%
Q3 2019+5.8%+14.1%+33.1%
Q2 2019+4.3%+6.0%+12.9%
Q1 2019-9.0%-8.8%-34.0%
Q4 2018-1.1%+1.4%-9.1%
Q3 2018-16.9%-18.4%-33.2%
Q2 2018-0.6%-0.6%+30.8%
Q1 2018-8.8%-10.3%+29.4%
Q4 2017+12.2%+9.6%+20.9%
Q3 2017-10.0%-13.3%-13.3%
Q2 2017-1.5%+0.0%-3.7%
Q1 2017-2.2%+0.7%+47.4%
Q4 2016-2.3%-6.3%-16.7%
Q3 2016-8.1%-4.1%+18.6%
Q2 2016+6.3%+5.8%+10.3%
Q1 2016+8.2%
Q4 2015+3.7%
Q2 2014-4.5%
Q4 2013
Q3 2013
Q2 2013
Q1 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro